pubrio
Oxipit

Oxipit

Lithuania · Information Technology & Services

Information Technology & Services

Medical Devices

Healthcare

Oxipit is an AI medical imaging software company founded in 2017. It specializes in developing advanced AI applications that enhance radiology diagnostics and workflows. The company uses deep learning and computer vision to create clinically impactful, certified AI solutions aimed at addressing the global shortage of radiologists and improving diagnostic quality. Oxipit's flagship product, ChestEye, is a CE Class IIb certified medical device that processes chest X-ray images to generate comprehensive radiological reports. This solution automates routine chest X-ray analysis, allowing radiologists to concentrate on more complex cases. The company also offers ChestLink, the first autonomous AI imaging application that can produce final chest X-ray reports without radiologist involvement when the AI is confident there are no abnormalities. Oxipit is expanding its offerings with the CT Suite, an AI-driven solution for improving CT imaging workflows, which is pending CE certification. Oxipit's customers include healthcare providers and radiology departments across Germany, the United Kingdom, France, and other countries, showcasing its international presence and the trust in its AI solutions. The company has received multiple awards for its innovation and impact in the field.

Company Insights
Company Overview

2017

Founded

Information Technology & Services

Industry

Lithuania

Location

3,365,865

Ranking

22 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Oxipit

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​